BioAtla, Inc.

BioAtla, Inc.

BCAB · Nasdaq

BioAtla, Inc. (BCAB) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for BioAtla, Inc. in 2026. The next earnings report is expected on November 18, 2026.

Earnings calendar

Next earnings date

18 Nov 2026

In 89 days

EPS estimate

-7.00

Revenue estimate

0

Past earnings

13 Aug 2026
EPS actual
—
estimate -8.50
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
31 Mar 2026
EPS actual
-8.00 (+33.3%)
estimate -12.00
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
30 Mar 2026
EPS actual
—
estimate -0.24
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
13 Nov 2025
EPS actual
-0.27 (+9.0%)
estimate -0.30
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Jay Short
Employees
61
IPO date
16 Dec 2020
ISIN
US09077B1044
Website
bioatla.com

Frequently asked questions

When does BioAtla, Inc. (BCAB) next report earnings?

BioAtla, Inc. (BCAB) is scheduled to report earnings on November 18, 2026.

What was BioAtla, Inc.'s most recent earnings date?

BioAtla, Inc. (BCAB) last reported earnings on August 13, 2026.

Where is BioAtla, Inc. stock listed?

BioAtla, Inc. (BCAB) is listed on Nasdaq.